Fortress Biotech, Inc.
FBIONASDAQHealthcare● Active
$2.85
+$0.20(+7.55%)
Market Cap$94674355
P/E Ratio—
52W High$4.53
52W Low$1.7
Fortress Biotech, Inc. (FBIO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FBIO · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $63.26M | $57.67M | $84.51M | $75.74M | $68.79M |
| Cost of Revenue | $20.92M | $20.88M | $22.89M | $30.77M | $32.08M |
| Gross Profit | $42.34M | $36.80M | $61.62M | $44.97M | $36.71M |
| Gross Margin %(computed) | 66.92% | 63.80% | 72.91% | 59.37% | 53.36% |
| Operating Expenses | |||||
| R&D Expenses | $11.90M | $56.88M | $106.07M | $134.88M | $128.87M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $112.56M | $147.18M | $203.96M | $248.53M | $225.25M |
| Operating Income | ($70.22M) | ($110.38M) | ($142.34M) | ($203.56M) | ($188.54M) |
| Operating Margin %(computed) | -111.00% | -191.38% | -168.43% | -268.76% | -274.08% |
| Interest Income | $2.48M | $2.68M | $3.00M | $1.40M | $0.65M |
| Interest Expense | $8.71M | $9.93M | $12.52M | $13.64M | $15.31M |
| Income Before Tax | ($33.53M) | ($120.54M) | ($153.63M) | ($213.46M) | ($164.35M) |
| Income Tax Expense | ($0.62M) | $0.31M | $0.52M | $0.45M | $0.47M |
| Net Income | $6.82M | ($46.00M) | ($60.64M) | ($86.58M) | ($64.70M) |
| Net Margin %(computed) | 10.77% | -79.75% | -71.75% | -114.30% | -94.06% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.07 | $-2.69 | $-8.47 | $-14.55 | $-11.85 |
| Wtd Avg Shares | 27.90M | 20.78M | 8.11M | 5.92M | 5.45M |
| EBITDA | ($20.16M) | ($104.49M) | ($135.72M) | ($193.69M) | ($146.17M) |
| EBITDA Margin %(computed) | -31.88% | -181.17% | -160.59% | -255.73% | -212.48% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Fortress Biotech, Inc. data
About Fortress Biotech, Inc. (FBIO) Income Statement
Fortress Biotech, Inc. (FBIO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, FBIO reported revenue of $0.06B, gross profit of $0.04B (gross margin 66.92%), and net income of $0.01B — a net profit margin of 10.77%.
Frequently asked questions
FBIO · 4 questionsFortress Biotech, Inc. (FBIO) reported revenue of $0.06B for 2025, up 9.7% year-over-year.
FBIO revenueFBIO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09